TD Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

TD Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.6K	Buy	44 +6	+16%	+$3.26K	﹤0.01%	356
2025 Q4	$22K	Hold	38	–	–	﹤0.01%	338
2025 Q3	$18.4K	Hold	38	–	–	﹤0.01%	335
2025 Q2	$15.4K	Buy	38 +29	+322%	+$12.1K	﹤0.01%	356
2025 Q1	$4.49K	Hold	9	–	–	﹤0.01%	400
2024 Q4	$4.68K	Buy	9 +5	+125%	+$2.75K	﹤0.01%	359
2024 Q3	$2.48K	Hold	4	–	–	﹤0.01%	382
2024 Q2	$2.21K	Hold	4	–	–	﹤0.01%	357
2024 Q1	$2.33K	Buy	+4	New	+$2.25K	﹤0.01%	374

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TD Capital Management's TMO Position: Q1 2026 in Review

TD Capital Management increased its Thermo Fisher Scientific (TMO) stake by 16% in Q1 2026, buying an estimated $3.26K and bringing the position to 44 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

TD Capital Management first reported a position in TMO in Q1 2024 and has held it in 9 quarters since. The position peaked at $22K in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

TD Capital Management held 44 shares of Thermo Fisher Scientific worth $21.6K as of Q1 2026.
TD Capital Management bought 6 Thermo Fisher Scientific shares in Q1 2026, an estimated $3.26K.
Thermo Fisher Scientific made up ﹤0.01% of TD Capital Management's portfolio in Q1 2026, its #356 holding.
TD Capital Management first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 9 quarters since.
TD Capital Management's Thermo Fisher Scientific position peaked at $22K in Q4 2025.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.